Scarica l'app Stockscreener
20.54
0.24%
-0.05
Pre-mercato:
20.98
0.44
+2.14%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CPRX Giù?
Forum
Previsione
Precedente Chiudi:
$20.59
Aprire:
$20.59
Volume 24 ore:
1.50M
Relative Volume:
1.10
Capitalizzazione di mercato:
$2.51B
Reddito:
$460.48M
Utile/perdita netta:
$142.80M
Rapporto P/E:
17.41
EPS:
1.18
Flusso di cassa netto:
$221.79M
1 W Prestazione:
+3.01%
1M Prestazione:
-2.75%
6M Prestazione:
-10.27%
1 anno Prestazione:
+1.43%
Intervallo 1D:
$20.34
$21.19
Intervallo di 1 settimana:
$19.94
$21.19
Portata 52W:
$19.00
$26.58
Catalyst Pharmaceuticals Inc Stock (CPRX) Company Profile
Nome
Catalyst Pharmaceuticals Inc
Settore
Industria
Telefono
(305) 529-2522
Indirizzo
355 ALHAMBRA CIRCLE, CORAL GABLES
Confronta CPRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CPRX
Catalyst Pharmaceuticals Inc
|
20.54 | 2.52B | 460.48M | 142.80M | 221.79M | 1.18 |
|
VRTX
Vertex Pharmaceuticals Inc
|
401.00 | 100.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.90 | 61.55B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.00 | 58.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
706.41 | 43.59B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.04 | 33.67B | 3.81B | -644.79M | -669.77M | -6.24 |
Catalyst Pharmaceuticals Inc Stock (CPRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-04 | Iniziato | Robert W. Baird | Outperform |
| 2024-11-18 | Iniziato | Stephens | Overweight |
| 2024-03-14 | Iniziato | Citigroup | Buy |
| 2024-03-07 | Iniziato | BofA Securities | Buy |
| 2023-12-21 | Iniziato | Oppenheimer | Outperform |
| 2022-08-24 | Downgrade | ROTH Capital | Buy → Neutral |
| 2018-09-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-09-07 | Ripresa | Piper Jaffray | Overweight |
| 2016-10-05 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2016-04-26 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2014-09-30 | Reiterato | ROTH Capital | Buy |
| 2014-09-16 | Reiterato | ROTH Capital | Buy |
| 2014-09-15 | Reiterato | H.C. Wainwright | Buy |
| 2013-10-21 | Reiterato | Aegis Capital | Buy |
| 2013-09-24 | Iniziato | Maxim Group | Buy |
| 2013-09-06 | Reiterato | Aegis Capital | Buy |
| 2013-04-18 | Iniziato | Aegis Capital | Buy |
| 2012-08-27 | Aggiornamento | Rodman & Renshaw | Mkt Perform → Mkt Outperform |
| 2009-10-01 | Aggiornamento | Merriman | Sell → Neutral |
| 2009-05-29 | Downgrade | Hapoalim | Neutral → Underperform |
| 2009-05-29 | Downgrade | Merriman Curhan Ford | Buy → Sell |
| 2008-12-15 | Iniziato | Merriman Curhan Ford | Buy |
| 2007-11-28 | Iniziato | Rodman & Renshaw | Mkt Outperform |
| 2007-01-31 | Iniziato | Stifel Nicolaus | Buy |
| 2007-01-05 | Iniziato | First Albany | Buy |
Mostra tutto
Catalyst Pharmaceuticals Inc Borsa (CPRX) Ultime notizie
Using R and stats models for Catalyst Pharmaceuticals Inc. forecastingChart Signals & AI Enhanced Trading Signals - Newser
Catalyst Pharmaceuticals Inc. stock trend outlook and recovery pathTrade Exit Report & Safe Capital Growth Plans - Newser
Market reaction to Catalyst Pharmaceuticals Inc.’s recent newsWeekly Profit Report & Daily Chart Pattern Signals - Newser
Is Catalyst Pharmaceuticals Inc. impacted by rising ratesGold Moves & Free Community Supported Trade Ideas - خودرو بانک
How to read the order book for Catalyst Pharmaceuticals Inc.Insider Buying & Real-Time Market Trend Scan - Newser
How is Catalyst Pharmaceuticals Inc. managing supply chain issuesJuly 2025 Setups & Growth Oriented Trade Recommendations - خودرو بانک
Is Catalyst Pharmaceuticals Inc. in a bullish channelJuly 2025 Technicals & AI Powered Market Entry Ideas - خودرو بانک
What indicators show strength in Catalyst Pharmaceuticals Inc.July 2025 Analyst Calls & Daily Technical Forecast Reports - Newser
Tools to assess Catalyst Pharmaceuticals Inc.’s risk profileWeekly Trade Summary & AI Enhanced Market Trend Forecasts - Newser
How high can Catalyst Pharmaceuticals Inc. stock goShort Setup & AI Powered Market Trend Analysis - Newser
What momentum shifts mean for Catalyst Pharmaceuticals Inc.July 2025 Fed Impact & Stepwise Trade Signal Guides - Newser
Is Catalyst Pharmaceuticals Inc. reversing from oversold territoryJuly 2025 Sentiment & Fast Moving Stock Watchlists - Newser
Will Catalyst Pharmaceuticals Inc. price bounce be sustainableEarnings Overview Report & Capital Efficiency Focused Strategies - Newser
Should you hold or exit Catalyst Pharmaceuticals Inc. nowPortfolio Gains Summary & Reliable Intraday Trade Alerts - Newser
Should I set a stop loss on Catalyst Pharmaceuticals Inc.Weekly Risk Report & Real-Time Market Sentiment Reports - خودرو بانک
Is Catalyst Pharmaceuticals Inc. gaining market shareWeekly Trade Review & Reliable Entry Point Alerts - خودرو بانک
Detecting support and resistance levels for Catalyst Pharmaceuticals Inc.Index Update & Long-Term Growth Plans - Newser
What is Catalyst Pharmaceuticals Inc. s 5 year growth outlook2025 Growth vs Value & Accurate Intraday Trading Signals - خودرو بانک
How to monitor Catalyst Pharmaceuticals Inc. with trend dashboardsJuly 2025 Rallies & Community Supported Trade Ideas - Newser
Is Catalyst Pharmaceuticals Inc. stock a hidden gem2025 Institutional Moves & AI Driven Stock Movement Reports - خودرو بانک
Is Catalyst Pharmaceuticals Inc. stock entering bullish territoryWatch List & Verified Technical Trade Signals - Newser
What is the next catalyst for Eupraxia Pharmaceuticals Inc.2025 Buyback Activity & Fast Moving Stock Watchlists - خودرو بانک
Sector ETF performance correlation with Catalyst Pharmaceuticals Inc.2025 Top Decliners & Step-by-Step Swing Trade Plans - Newser
Heatmap analysis for Catalyst Pharmaceuticals Inc. and competitorsBreakout Watch & Technical Entry and Exit Tips - Newser
Does Catalyst Pharmaceuticals Inc. have pricing powerJuly 2025 Drop Watch & High Accuracy Swing Entry Alerts - خودرو بانک
Catalyst Pharmaceuticals Inc. Sees Spike in Bullish Option FlowJuly 2025 Drop Watch & Technical Confirmation Alerts - beatles.ru
Using data models to predict Catalyst Pharmaceuticals Inc. stock movementWeekly Loss Report & Free Low Drawdown Momentum Trade Ideas - Newser
Should you wait for a breakout in Catalyst Pharmaceuticals Inc.Oil Prices & AI Forecast Swing Trade Picks - Newser
News impact scoring models applied to Catalyst Pharmaceuticals Inc.Bull Run & Risk Controlled Stock Pick Alerts - Newser
Statistical indicators supporting Catalyst Pharmaceuticals Inc.’s strengthPortfolio Growth Summary & Low Drawdown Trading Techniques - Newser
Is Catalyst Pharmaceuticals Inc. building a consolidation baseJuly 2025 Review & Technical Buy Zone Confirmation - Newser
Published on: 2025-08-30 22:54:38 - beatles.ru
Short Interest Drops in Catalyst Pharmaceuticals Inc. After RallyJuly 2025 Sentiment & Safe Capital Growth Stock Tips - beatles.ru
Catalyst Pharmaceuticals Secures Exclusivity for FIRDAPSE Until 2035 - AInvest
Catalyst Pharmaceuticals Inc. stock trendline breakdownMarket Rally & Weekly Top Stock Performers List - Newser
Risk vs reward if holding onto Catalyst Pharmaceuticals Inc.Earnings Trend Report & Free Low Drawdown Momentum Trade Ideas - Newser
Identifying reversal signals in Catalyst Pharmaceuticals Inc.July 2025 Levels & Low Risk Entry Point Guides - Newser
Catalyst Pharmaceuticals Inc. stock prediction for this weekTrade Analysis Report & Momentum Based Trading Ideas - Newser
Strategies to average down on Catalyst Pharmaceuticals Inc.Weekly Profit Recap & AI Driven Price Forecasts - Newser
Catalyst Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
How to recover losses in Catalyst Pharmaceuticals Inc. stockPortfolio Update Summary & Free Fast Gain Swing Trade Alerts - Newser
Catalyst Pharmaceuticals Inc Azioni (CPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):